As of Tuesday, January 06, Regencell Bioscience Holdings Limited’s RGC share price has surged by 12.65%, which has investors ...
Hosted on MSN
Oppenheimer Downgrades Spruce Biosciences (SPRB)
Fintel reports that on December 11, 2024, Oppenheimer downgraded their outlook for Spruce Biosciences (NasdaqCM:SPRB) from Outperform to Perform. Analyst Price Forecast Suggests 374.86% Upside As of ...
As of Wednesday, December 31, Pacific Biosciences of California, Inc.’s PACB share price has surged by 5.49%, which has ...
Hosted on MSN
Keybanc Downgrades Harvard Bioscience (HBIO)
Fintel reports that on April 8, 2025, Keybanc downgraded their outlook for Harvard Bioscience (NasdaqGM:HBIO) from Overweight to Sector Weight. Analyst Price Forecast Suggests 944.80% Upside As of ...
As of May 11, 2023, the average one-year price target for Ideaya Biosciences is 34.11. The forecasts range from a low of 24.24 to a high of $45.15. The average price target represents an increase of ...
The average one-year price target for Twist Bioscience (NASDAQ:TWST) has been revised to 28.05 / share. This is an increase of 5.36% from the prior estimate of 26.62 dated October 31, 2023. The price ...
The average one-year price target for Enveric Biosciences (NasdaqCM:ENVB) has been revised to 9.18 / share. This is an increase of 5.88% from the prior estimate of 8.67 dated January 16, 2024. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback